Assessment of the reporting quality of double-blind RCTs for ischemic stroke based on the CONSORT statement

It is critical that Randomized Controlled Trials(RCTs) present complete and transparent reporting. The present study aims to determine the reporting quality of double-blind RCTs for medicinal interventions in patients with ischemic stroke, based on the 2010 CONSORT-statement.

from Journal of the Neurological Sciences https://ift.tt/2X7pwYZ